149 related articles for article (PubMed ID: 30142535)
1. Elevated soluble syndecan-1 levels in neuromyelitis optica are associated with disease severity.
Pei S; Zheng D; Wang Z; Hu X; Pan S; Wang H
Cytokine; 2018 Nov; 111():140-145. PubMed ID: 30142535
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
[TBL] [Abstract][Full Text] [Related]
3. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.
Liu B; Zhong X; Lu Z; Qiu W; Hu X; Wang H
Neuroimmunomodulation; 2018; 25(4):185-192. PubMed ID: 30423585
[TBL] [Abstract][Full Text] [Related]
6. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
[TBL] [Abstract][Full Text] [Related]
7. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
[TBL] [Abstract][Full Text] [Related]
8. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
[TBL] [Abstract][Full Text] [Related]
10. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y
BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability.
Tomizawa Y; Yokoyama K; Saiki S; Takahashi T; Matsuoka J; Hattori N
J Int Med Res; 2012; 40(4):1483-91. PubMed ID: 22971500
[TBL] [Abstract][Full Text] [Related]
13. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.
Uzawa A; Mori M; Ito M; Uchida T; Hayakawa S; Masuda S; Kuwabara S
J Neurol; 2009 Dec; 256(12):2082-4. PubMed ID: 19655191
[TBL] [Abstract][Full Text] [Related]
14. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.
Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A
Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble C5b-9 in CSF of neuromyelitis optica.
Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X
Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum level of IL-4 in neuromyelitis optica and multiple sclerosis patients.
Tahani S; Dehghani L; Jahanbani-Ardakani H; Shaygannejad V; Fazli A; Hamidavi A; Eskandari N
J Immunoassay Immunochem; 2019; 40(5):555-563. PubMed ID: 31422745
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
[TBL] [Abstract][Full Text] [Related]
20. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.
Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG
Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
